Christian Brun-Buisson, MD is professor of medicine and Intensive Care at University Paris-Est Créteil, and former director of the Medical Intensive Care Unit and of the Infection control unit at Henri Mondor Hospital. His areas of expertise include sepsis and severe infections, prevention and control of health-care associated infections and epidemiology and control of antimicrobial resistance. He has chaired the Infection Control Committee of the Paris public hospitals consortium (AP-HP, 1999-2011) and chairs (2005 – 2017) the Advisory Board for the French national programme for Prevention and Control of Health-Care Associated Infections at the MoH. Prof. Brun-Buisson has served on the editorial board of several medical journals, including JAMA, Am J Resp Crit Care Med, Intensive Care Med, and Infect Control Hosp Epidemiology. He is currently ministerial delegate for antimicrobial resistance at the French ministry of Health and Social Affairs.
MIBAC: Antibiotic use in the community
Since 2002 a centralized storage of therapeutic or preventive medications of bacterial infections in the community (MIBAC) has been initiated. Reimbursements for all systemic antibiotics (class J01 of the Anatomical Therapeutic classification), as well […]
PHIBRA: Bacterial resistance to antibiotics
Bacterial resistance to antibiotics has become a major public health issue. A recent report, coordinated by Jean Carlet and delivered to the Minister of Health in September 2015, pointed out 158,000 cases of infections […]
2019A Payer Perspective of the Hospital Inpatient Additional Care Costs of Antimicrobial Resistance in France: A Matched Case-Control Study, Appl Health Econ Health Policy 2019 Jun;17(3):381-389.
2019Hospitalisations with infections related to antimicrobial-resistant bacteria from the French nationwide hospital discharge database, 2016, Epidemiol. Infect. 2019 Jan;147:e144.
2017Comparing antibiotic consumption between two European countries: are packages an adequate surrogate for prescriptions?, Euro Surveill. 2017 Nov;22(46).